Overview


According to FutureWise analysis the market for sterile injectables in 2023 is US$ 513.57 billion, and is expected to reach US$ 917.31 billion by 2031 at a CAGR of 7.5%.

The term sterile injectable refers to biologics that are used to treat a variety of diseases and have the same active ingredients as branded versions, but different inactive contents.An injectable is a compounded pharmaceutical that is injected into the body using a needle and syringe through a variety of routes, including intravascular (iv), subcutaneous (sc), intramuscular (im), and other routes. Sterile injectables are used to treat a wide range of symptoms and diseases, including the following (cardio vascular diseases, central nervous system disorder, metabolic disorders, and others).Sterile injections are becoming a popular way to administer medication therapy at home. Sterile inject medicine is commonly used by insulin-dependent diabetics and people with arthritis because it is a simple and reliable way to sterile administer medications. Over the forecast period, demand for sterile injectables is predicted to rise due to an increasing preference for sterile injectables over traditional pharmaceuticals due to its high absorbability and rapid therapeutic response in the body. This has prompted the pharmaceutical industry to place a greater emphasis on biologics and develop new medications. Manufacturers of sterile injectables are pursuing mergers and acquisitions as a means of expanding their product portfolio, which is likely to enhance the global sterile injectables market growth throughout the forecast period.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Sterile Injectables Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Sterile Injectables Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Baxter International Inc.
  • AstraZeneca plc.
  • MerckCo., Inc.
  • Novartis AG
  • Johnson and Johnson Services, Inc.
  • Gilead Sciences, Inc.
  • JHP Pharmaceuticals
  • Pfizer Inc.
  • Fresenius Kabi Ag
  • CordenPharma
  • Hikma Pharmaceuticals PLC.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Molecule Type

  • Large Molecules
  • Small Molecules

By Drug Type

  • Monoclonal Antibodies (mAbs)
  • Cytokines
  • Insulin
  • Peptide Hormones
  • Vaccines
  • Immunoglobulins
  • Blood Factors
  • Peptide Antibiotics
  • Others

By Therapeutic Application

  • Cancer
  • Metabolic Diseases
  • Cardiovascular Diseases
  • Central Nervous Systems Disorders
  • Infectious Disorders
  • Musculoskeletal Disorders
  • Others

By Route of Administration

  • Subcutaneous (SC)
  • Intravenous (IV)
  • Intramuscular (IM)
  • Others

By Distribution Channels

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Sterile Injectables Market By Molecule Type, By Drug Type, By Therapeutic Application, By Route of Administration, By Distribution Channels and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Sterile Injectables Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Sterile Injectables Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Sterile Injectables Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Sterile Injectables Market, By Molecule Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Large Molecules
        2. Small Molecules

  • 8.   Sterile Injectables Market, By Drug Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Monoclonal Antibodies (mAbs)
        2. Cytokines
        3. Insulin
        4. Peptide Hormones
        5. Vaccines
        6. Immunoglobulins
        7. Blood Factors
        8. Peptide Antibiotics
        9. Others

  • 9.   Sterile Injectables Market, By Therapeutic Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Cancer
        2. Metabolic Diseases
        3. Cardiovascular Diseases
        4. Central Nervous Systems Disorders
        5. Infectious Disorders
        6. Musculoskeletal Disorders
        7. Others

  • 10.   Sterile Injectables Market, By Route of Administrations Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Subcutaneous (SC)
        2. Intravenous (IV)
        3. Intramuscular (IM)
        4. Others

  • 11.   Sterile Injectables Market, By Distribution Channels Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies

  • 12.   North America Sterile Injectables Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America Sterile Injectables Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe Sterile Injectables Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific Sterile Injectables Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •      1. Baxter International Inc.
               1.1. Company Overview
               1.2. Product Portfolio
               1.3. SWOT Analysis
               1.4. Financial Overview
               1.5. Strategic Overview
           2. AstraZeneca plc.
               2.1. Company Overview
               2.2. Product Portfolio
               2.3. SWOT Analysis
               2.4. Financial Overview
               2.5. Strategic Overview
           3. Merck & Co., Inc.
               3.1. Company Overview
               3.2. Product Portfolio
               3.3. SWOT Analysis
               3.4. Financial Overview
               3.5. Strategic Overview
           4. Novartis AG
               4.1. Company Overview
               4.2. Product Portfolio
               4.3. SWOT Analysis
               4.4. Financial Overview
               4.5. Strategic Overview
           5. Johnson & Johnson Services, Inc.
               5.1. Company Overview
               5.2. Product Portfolio
               5.3. SWOT Analysis
               5.4. Financial Overview
               5.5. Strategic Overview          
           6. Gilead Sciences, Inc.
               6.1. Company Overview
               6.2. Product Portfolio
               6.3. SWOT Analysis
               6.4. Financial Overview
               6.5. Strategic Overview
           7. JHP Pharmaceuticals
               7.1. Company Overview
               7.2. Product Portfolio
               7.3. SWOT Analysis
               7.4. Financial Overview
               7.5. Strategic Overview
           8. Pfizer Inc.
               8.1. Company Overview
               8.2. Product Portfolio
               8.3. SWOT Analysis
               8.4. Financial Overview
               8.5. Strategic Overview
           9. Fresenius Kabi Ag
               9.1. Company Overview
               9.2. Product Portfolio
               9.3. SWOT Analysis
               9.4. Financial Overview
               9.5. Strategic Overview          
           10. CordenPharma
               10.1. Company Overview
               10.2. Product Portfolio
               10.3. SWOT Analysis
               10.4. Financial Overview
               10.5. Strategic Overview
           11. Hikma Pharmaceuticals PLC.
               11.1. Company Overview
               11.2. Product Portfolio
               11.3. SWOT Analysis
               11.4. Financial Overview
               11.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 20.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients